Literature DB >> 12562519

GABAB receptor mRNA in the raphe nuclei: co-expression with serotonin transporter and glutamic acid decarboxylase.

Jordi Serrats1, Francesc Artigas, Guadalupe Mengod, Roser Cortés.   

Abstract

We have used double-label in situ hybridization techniques to examine the cellular localization of GABAB receptor mRNA in relation to serotonin transporter mRNA and glutamic acid decarboxylase mRNA in the rat dorsal raphe, median raphe and raphe magnus nuclei. The degree of cellular co-localization of these markers notably varied among the different nuclei. In the dorsal raphe, cell bodies showing GABAB receptor mRNA were very abundant, the 85% being also labelled for serotonin transporter mRNA, and a low proportion (5%) showing glutamic acid decarboxylase mRNA. In the median raphe, the level of co-expression of GABAB receptor mRNA with serotonin transporter mRNA was significantly lower. Some cells were also identified that contained GABAB receptor mRNA in the absence of either one of the other mRNA species studied. Our results support the presence of GABAB receptors in serotonergic as well as GABAergic neurones in the dorsal and median raphe, providing the anatomical basis for the reported dual inhibitory/disinhibitory effect of the GABAB agonist baclofen on serotonergic function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12562519     DOI: 10.1046/j.1471-4159.2003.01557.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  13 in total

1.  Differential expression of 5HT-1A, alpha 1b adrenergic, CRF-R1, and CRF-R2 receptor mRNA in serotonergic, gamma-aminobutyric acidergic, and catecholaminergic cells of the rat dorsal raphe nucleus.

Authors:  Heidi E W Day; Benjamin N Greenwood; Sayamwong E Hammack; Linda R Watkins; Monika Fleshner; Steven F Maier; Serge Campeau
Journal:  J Comp Neurol       Date:  2004-06-28       Impact factor: 3.215

2.  Local GABAergic modulation of the activity of serotoninergic neurons in the nucleus raphe magnus.

Authors:  A N Inyushkin; N A Merkulova; A O Orlova; E M Inyushkina
Journal:  Neurosci Behav Physiol       Date:  2010-08-03

3.  Behavioral characterization of escalated aggression induced by GABA(B) receptor activation in the dorsal raphe nucleus.

Authors:  Aki Takahashi; Arielle N Schilit; Jisoo Kim; Joseph F Debold; Tsuyoshi Koide; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2012-03-07       Impact factor: 4.530

4.  GABA(B) receptor modulation of serotonin neurons in the dorsal raphé nucleus and escalation of aggression in mice.

Authors:  Aki Takahashi; Akiko Shimamoto; Christopher O Boyson; Joseph F DeBold; Klaus A Miczek
Journal:  J Neurosci       Date:  2010-09-01       Impact factor: 6.167

5.  NMDA antagonist and antipsychotic actions in cortico-subcortical circuits.

Authors:  Lucila Kargieman; Noemí Santana; Guadalupe Mengod; Pau Celada; Francesc Artigas
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

6.  The GABAB receptor agonist baclofen administered into the median and dorsal raphe nuclei is rewarding as shown by intracranial self-administration and conditioned place preference in rats.

Authors:  Rick Shin; Satoshi Ikemoto
Journal:  Psychopharmacology (Berl)       Date:  2010-03       Impact factor: 4.530

7.  Fluoxetine partly exerts its actions through GABA: a neurochemical evidence.

Authors:  M Zafer Gören; Esra Küçükibrahimoglu; Kemal Berkman; Berna Terzioglu
Journal:  Neurochem Res       Date:  2007-05-08       Impact factor: 3.996

Review 8.  Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands.

Authors:  Elaine C Gavioli; Girolamo Calo'
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-02-21       Impact factor: 3.000

9.  The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression.

Authors:  Esra Küçükibrahimoğlu; Melek Z Saygin; Mecit Calişkan; Okan K Kaplan; Cüneyt Unsal; M Zafer Gören
Journal:  Eur J Clin Pharmacol       Date:  2009-04-17       Impact factor: 2.953

10.  A human laboratory pilot study with baclofen in alcoholic individuals.

Authors:  Lorenzo Leggio; William H Zywiak; John E McGeary; Steven Edwards; Samuel R Fricchione; Jessica R Shoaff; Giovanni Addolorato; Robert M Swift; George A Kenna
Journal:  Pharmacol Biochem Behav       Date:  2012-12-19       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.